FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX, Inc. (NYSE: MD), today announced the acquisition of Maternal Fetal Medicine of Southwest Florida, P.A. a private physician group practice based in Fort Myers, Fla.
Maternal Fetal Medicine of Southwest Florida was established in 2000 and currently has four physicians, 11 sonographers and 26 other clinical and administrative staff who provide a full spectrum of perinatology and sonographic services including comprehensive high-risk maternal-fetal medicine, ultrasounds, amniocentesis, diagnostic testing and genetic counseling.
The practice has four patient offices in Fort Myers, Cape Coral, Port Charlotte, and Naples and serves six hospitals, including the four acute care hospitals of Lee Memorial Health System (Lee Memorial Hospital, HealthPark Medical Center, Gulf Coast Medical Center, and Cape Coral Hospital) as well as NCH North Naples Hospital, part of NCH Healthcare System and Bayfront Health Port Charlotte, part of Bayfront Health.
“MEDNAX’s extensive research, education and quality programs were definitely a differentiator for us,” said Judith Krammer, M.D., who will serve as medical director for the practice. “Joining MEDNAX also gives us the infrastructure we need to excel in today’s healthcare environment as well as the ability to be part of the continuum of care the company currently provides in Southwest Florida with industry-leading neonatal and pediatric services.”
This acquisition adds to the services MEDNAX provides in Southwest Florida which currently include maternal-fetal medicine (perinatology), neonatology, pediatric cardiology and newborn hearing screen.
This was a cash transaction, and it is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed.
With this acquisition, ten physician group practices have become part of MEDNAX in 2016.
ABOUT MEDNAX
MEDNAX, Inc. is a national health solutions partner comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX provides services through a network of more than 3,400 physicians in all 50 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40 states through two complementary businesses, consisting of a revenue cycle management company and a consulting services company. Additional information is available at www.mednax.com.
Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.
